Craven House Capital Plc (CRV.L)
USD 0.19
(8.57%)
USD 0.19
(8.57%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 186 Thousand USD | 3.33% |
| 2021 | 180 Thousand USD | -13.46% |
| 2020 | 208 Thousand USD | 128.93% |
| 2019 | -719 Thousand USD | -131.5% |
| 2018 | 2.28 Million USD | 131.73% |
| 2017 | 985 Thousand USD | 84.11% |
| 2016 | 535 Thousand USD | -1.78% |
| 2015 | 544.67 Thousand USD | 55.29% |
| 2014 | 350.75 Thousand USD | -31.83% |
| 2013 | 514.5 Thousand USD | -65.84% |
| 2012 | 1.5 Million USD | 278.61% |
| 2011 | 397.8 Thousand USD | 17.16% |
| 2010 | 339.54 Thousand USD | 152.74% |
| 2009 | 134.34 Thousand USD | 0.0% |
| 2007 | 200.29 Thousand USD | -95.3% |
| 2006 | 4.25 Million USD | 12.62% |
| 2005 | 3.78 Million USD | 18.02% |
| 2004 | 3.2 Million USD | 80.1% |
| 2003 | 1.77 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | 38.50 USD | -100.0% |
| 2023 Q2 | 38.50 USD | -0.0% |
| 2022 FY | 186 Thousand USD | 3.33% |
| 2022 Q2 | 36.00 USD | 0.0% |
| 2022 Q1 | 36.00 USD | -29.41% |
| 2022 Q4 | 5.37 Million USD | 0.0% |
| 2021 Q3 | 51.00 USD | 30.77% |
| 2021 Q4 | 51.00 USD | 0.0% |
| 2021 Q1 | 39.00 USD | -96.63% |
| 2021 FY | 180 Thousand USD | -13.46% |
| 2021 Q2 | 39.00 USD | 0.0% |
| 2020 Q4 | 1156.00 USD | 0.0% |
| 2020 Q1 | 59.50 USD | -98.45% |
| 2020 Q2 | 59.50 USD | 0.0% |
| 2020 Q3 | 1156.00 USD | 1842.86% |
| 2020 FY | 208 Thousand USD | 128.93% |
| 2019 FY | -719 Thousand USD | -131.5% |
| 2019 Q3 | 3827.11 USD | 34.85% |
| 2019 Q4 | 3827.11 USD | 0.0% |
| 2019 Q1 | 2838.00 USD | 100.19% |
| 2019 Q2 | 2838.00 USD | 0.0% |
| 2018 Q1 | 1720.00 USD | 2133.77% |
| 2018 Q4 | -1.53 Million USD | -199906.06% |
| 2018 FY | 2.28 Million USD | 131.73% |
| 2018 Q2 | 1720.00 USD | 0.0% |
| 2018 Q3 | 766.74 USD | -55.42% |
| 2017 Q4 | 77.00 USD | 0.0% |
| 2017 FY | 985 Thousand USD | 84.11% |
| 2017 Q1 | 274.50 USD | -63.2% |
| 2017 Q2 | 274.50 USD | 0.0% |
| 2017 Q3 | 77.00 USD | -71.95% |
| 2016 Q1 | 783.50 USD | 68.49% |
| 2016 Q4 | 746.00 USD | 0.0% |
| 2016 FY | 535 Thousand USD | -1.78% |
| 2016 Q3 | 746.00 USD | -4.79% |
| 2016 Q2 | 783.50 USD | 0.0% |
| 2015 Q1 | 61.44 USD | -38.58% |
| 2015 FY | 544.67 Thousand USD | 55.29% |
| 2015 Q4 | 465.02 USD | 128.58% |
| 2015 Q3 | 203.44 USD | 237.89% |
| 2015 Q2 | 60.21 USD | -2.01% |
| 2014 Q1 | 79.58 USD | -53.92% |
| 2014 Q2 | 75.09 USD | -5.65% |
| 2014 Q3 | 101.20 USD | 34.77% |
| 2014 Q4 | 100.04 USD | -1.15% |
| 2014 FY | 350.75 Thousand USD | -31.83% |
| 2013 Q2 | 82.71 USD | 5.88% |
| 2013 Q4 | 172.69 USD | 0.07% |
| 2013 FY | 514.5 Thousand USD | -65.84% |
| 2013 Q1 | 78.12 USD | -66.33% |
| 2013 Q3 | 172.57 USD | 108.64% |
| 2012 Q2 | 547.41 GBP | 0.95% |
| 2012 Q1 | 542.28 USD | 1230.42% |
| 2012 Q3 | 232.12 USD | -57.6% |
| 2012 Q4 | 232.01 USD | -0.05% |
| 2012 FY | 1.5 Million USD | 278.61% |
| 2011 Q1 | 2060.36 USD | 0.0% |
| 2011 FY | 397.8 Thousand USD | 17.16% |
| 2011 Q4 | 40.76 USD | -89.47% |
| 2011 Q3 | 386.97 USD | 0.0% |
| 2010 Q4 | 2060.36 USD | 0.0% |
| 2010 Q1 | -33.58 Thousand USD | 0.0% |
| 2010 Q3 | 2060.36 USD | 0.0% |
| 2010 FY | 339.54 Thousand USD | 152.74% |
| 2009 Q4 | -33.58 Thousand USD | 0.0% |
| 2009 Q3 | -33.58 Thousand USD | 0.0% |
| 2009 FY | 134.34 Thousand USD | 0.0% |
| 2007 Q1 | -634.11 Thousand USD | 0.0% |
| 2007 FY | 200.29 Thousand USD | -95.3% |
| 2006 Q3 | -634.11 Thousand USD | 0.0% |
| 2006 FY | 4.25 Million USD | 12.62% |
| 2006 Q4 | -634.11 Thousand USD | 0.0% |
| 2006 Q1 | 1.06 Million USD | 0.0% |
| 2005 Q3 | 1.06 Million USD | 0.0% |
| 2005 Q4 | 1.06 Million USD | 0.0% |
| 2005 FY | 3.78 Million USD | 18.02% |
| 2005 Q1 | 945.09 Thousand USD | 0.0% |
| 2004 Q1 | 800.79 Thousand USD | 0.0% |
| 2004 FY | 3.2 Million USD | 80.1% |
| 2004 Q4 | 945.09 Thousand USD | 0.0% |
| 2004 Q3 | 945.09 Thousand USD | 0.0% |
| 2003 Q1 | -15.17 Thousand USD | 0.0% |
| 2003 Q3 | 800.79 Thousand USD | 0.0% |
| 2003 Q4 | 800.79 Thousand USD | 0.0% |
| 2003 FY | 1.77 Million USD | 0.0% |
| 2002 Q4 | -15.17 Thousand USD | 0.0% |
| 2002 Q3 | -15.17 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Ameriprise Financial, Inc. | 15.53 Billion USD | 99.999% |
| Gladstone Investment Corporation | 39.1 Million USD | 99.524% |
| Principal Financial Group, Inc. | 5.07 Billion USD | 99.996% |
| Africa Opportunity Fund Limited | 1.68 Million USD | 88.989% |
| BH Macro Limited | 160.03 Million USD | 99.884% |
| BioPharma Credit PLC | 2.03 Million USD | 90.869% |
| CATCo Reinsurance Opportunities Fund Ltd. | -183.39 Thousand USD | 201.423% |
| JPEL Private Equity Limited | 1.17 Million USD | 84.116% |
| Pershing Square Holdings, Ltd. | 483.23 Million USD | 99.962% |
| Ecofin U.S. Renewables Infrastructure Trust PLC | -5.54 Million USD | 103.355% |
| RTW Venture Fund Limited | 86.29 Million USD | 99.784% |
| Tufton Oceanic Assets Limited | 1.01 Million USD | 81.65% |
| Symphony International Holdings Limited | 114.51 Million USD | 99.838% |
| Tetragon Financial Group Limited | 17.6 Million USD | 98.943% |
| Taylor Maritime Investments Limited | -42.53 Million USD | 100.437% |
| TMT Investments PLC | 1.28 Million USD | 85.47% |
| Third Point Investors Limited | 13.01 Million USD | 98.571% |